These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30954957)
1. Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. Tougaard NH; Faber J; Eldrup E BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30954957 [TBL] [Abstract][Full Text] [Related]
2. [Life-threatening ketoacidosis in patients with type 2 diabetes on LCHF diet]. Bonikowska K; Magnusson P; Sjöholm Å Lakartidningen; 2018 Jun; 115():. PubMed ID: 29969145 [TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose co-transporter 2 inhibitors in the peri-operative period: A warning to all clinicians. Waylen AL; Riedel B BJU Int; 2019 May; 123 Suppl 5():6-7. PubMed ID: 31116003 [No Abstract] [Full Text] [Related]
4. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report]. Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745 [TBL] [Abstract][Full Text] [Related]
5. Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes. Shamchuk A; Doulla M; Jetha M CMAJ; 2021 Sep; 193(35):E1385-E1388. PubMed ID: 34493565 [No Abstract] [Full Text] [Related]
6. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases]. Menghoum N; Oriot P; Hermans MP; Mariage JL Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073 [TBL] [Abstract][Full Text] [Related]
7. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Paul N; Jonklaas J Diabetes Metab Syndr; 2021; 15(1):361-363. PubMed ID: 33517150 [No Abstract] [Full Text] [Related]
8. SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient. Ritchie DT; Dixon J BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36113958 [TBL] [Abstract][Full Text] [Related]
9. Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment. Sampani E; Sarafidis P; Papagianni A Expert Opin Drug Saf; 2020 Jun; 19(6):673-682. PubMed ID: 32521174 [TBL] [Abstract][Full Text] [Related]
10. Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study. Yabe D; Iwasaki M; Kuwata H; Haraguchi T; Hamamoto Y; Kurose T; Sumita K; Yamazato H; Kanada S; Seino Y Diabetes Obes Metab; 2017 May; 19(5):739-743. PubMed ID: 27990776 [TBL] [Abstract][Full Text] [Related]
11. Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence. Thiruvenkatarajan V; Inglis JM; Meyer E; Umapathysivam MM; Nanjappa N; Van Wijk R; Jesudason D Can J Diabetes; 2023 Apr; 47(3):287-291. PubMed ID: 36739255 [TBL] [Abstract][Full Text] [Related]
12. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review. Sampani E; Sarafidis P; Dimitriadis C; Kasimatis E; Daikidou D; Bantis K; Papanikolaou A; Papagianni A BMC Nephrol; 2020 Jul; 21(1):276. PubMed ID: 32669085 [TBL] [Abstract][Full Text] [Related]
13. Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment. Storgaard H; Bagger JI; Knop FK; Vilsbøll T; Rungby J Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):168-70. PubMed ID: 26291182 [TBL] [Abstract][Full Text] [Related]
14. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Bamgboye AO; Oni IO; Collier A Eur J Clin Pharmacol; 2021 May; 77(5):651-657. PubMed ID: 33244632 [TBL] [Abstract][Full Text] [Related]
15. [Ketogenic diet as a trigger for diabetic euglycaemic ketoacidosis in a patient under treatment with iSGLT2]. Nubiola A; Ternianov A; Remolins I Hipertens Riesgo Vasc; 2020; 37(1):39-41. PubMed ID: 31734176 [TBL] [Abstract][Full Text] [Related]
16. The catabolic triad: case report of fasting, major cardiac surgery and sodium-glucose co-transporter 2 inhibitors leading to perioperative euglycaemic ketoacidosis. Smyth CC; Collins M; McCarthy J; Galvin S Interact Cardiovasc Thorac Surg; 2021 Aug; 33(3):494-495. PubMed ID: 33961026 [TBL] [Abstract][Full Text] [Related]
17. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series. Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418 [TBL] [Abstract][Full Text] [Related]
18. Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin). Latif A; Gastelum AA; Sood A; Reddy JT Drug Ther Bull; 2021 Jun; 59(6):93-95. PubMed ID: 33509834 [No Abstract] [Full Text] [Related]
19. Case Report: DKA with Lower-than-Expected Blood Glucose in the Setting of SGLT2 Inhibitor Use. Voskertchian A; Milanes L Am Fam Physician; 2021 Feb; 103(4):200. PubMed ID: 33587584 [No Abstract] [Full Text] [Related]
20. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Thiruvenkatarajan V; Meyer EJ; Nanjappa N; Van Wijk RM; Jesudason D Br J Anaesth; 2019 Jul; 123(1):27-36. PubMed ID: 31060732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]